These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 18004283

  • 1. Attenuation of the effects of corticosteroids on declarative memory with lamotrigine.
    Brown ES, Wolfshohl J, Shad MU, Vazquez M, Osuji IJ.
    Neuropsychopharmacology; 2008 Sep; 33(10):2376-83. PubMed ID: 18004283
    [Abstract] [Full Text] [Related]

  • 2. A randomized, double-blind, placebo-controlled trial of lamotrigine for prescription corticosteroid effects on the human hippocampus.
    Brown ES, Sayed N, Choi C, Tustison N, Roberts J, Yassa MA, Van Enkevort E, Nakamura A, Ivleva EI, Sunderajan P, Khan DA, Vazquez M, McEwen B, Kulikova A, Frol AB, Holmes T.
    Eur Neuropsychopharmacol; 2019 Mar; 29(3):376-383. PubMed ID: 30612854
    [Abstract] [Full Text] [Related]

  • 3. Effects of lamotrigine on hippocampal activation in corticosteroid-treated patients.
    Brown ES, Zaidel L, Allen G, McColl R, Vazquez M, Ringe WK.
    J Affect Disord; 2010 Nov; 126(3):415-9. PubMed ID: 20580827
    [Abstract] [Full Text] [Related]

  • 4. Effect of phenytoin on mood and declarative memory during prescription corticosteroid therapy.
    Brown ES, Stuard G, Liggin JD, Hukovic N, Frol A, Dhanani N, Khan DA, Jeffress J, Larkin GL, McEwen BS, Rosenblatt R, Mageto Y, Hanczyc M, Cullum CM.
    Biol Psychiatry; 2005 Mar 01; 57(5):543-8. PubMed ID: 15737670
    [Abstract] [Full Text] [Related]

  • 5. Attenuation of amygdala atrophy with lamotrigine in patients receiving corticosteroid therapy.
    Desai S, Khanani S, Shad MU, Brown ES.
    J Clin Psychopharmacol; 2009 Jun 01; 29(3):284-7. PubMed ID: 19440084
    [Abstract] [Full Text] [Related]

  • 6. Randomized, placebo-controlled, crossover trial of memantine for cognitive changes with corticosteroid therapy.
    Brown ES, Vazquez M, Nakamura A.
    Biol Psychiatry; 2008 Oct 15; 64(8):727-729. PubMed ID: 18582848
    [Abstract] [Full Text] [Related]

  • 7. A randomized, placebo-controlled proof-of-concept, crossover trial of phenytoin for hydrocortisone-induced declarative memory changes.
    Brown ES, Lu H, Denniston D, Uh J, Thomas BP, Carmody TJ, Auchus RJ, Diaz-Arrastia R, Tamminga C.
    J Affect Disord; 2013 Sep 05; 150(2):551-8. PubMed ID: 23453674
    [Abstract] [Full Text] [Related]

  • 8. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy.
    Brown ES, J Woolston D, Frol A, Bobadilla L, Khan DA, Hanczyc M, Rush AJ, Fleckenstein J, Babcock E, Cullum CM.
    Biol Psychiatry; 2004 Mar 01; 55(5):538-45. PubMed ID: 15023583
    [Abstract] [Full Text] [Related]

  • 9. A randomized trial of an NMDA receptor antagonist for reversing corticosteroid effects on the human hippocampus.
    Brown ES, Kulikova A, Van Enkevort E, Nakamura A, Ivleva EI, Tustison NJ, Roberts J, Yassa MA, Choi C, Frol A, Khan DA, Vazquez M, Holmes T, Malone K.
    Neuropsychopharmacology; 2019 Dec 01; 44(13):2263-2267. PubMed ID: 31181564
    [Abstract] [Full Text] [Related]

  • 10. Effect of two prednisone exposures on mood and declarative memory.
    Brown ES, Beard L, Frol AB, Rush AJ.
    Neurobiol Learn Mem; 2006 Jul 01; 86(1):28-34. PubMed ID: 16458545
    [Abstract] [Full Text] [Related]

  • 11. Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial.
    Belsito KM, Law PA, Kirk KS, Landa RJ, Zimmerman AW.
    J Autism Dev Disord; 2001 Apr 01; 31(2):175-81. PubMed ID: 11450816
    [Abstract] [Full Text] [Related]

  • 12. Mesial temporal lobe epilepsy: Revisiting the relation of hippocampal volumetry with memory deficits.
    Ono SE, de Carvalho Neto A, Joaquim MJM, Dos Santos GR, de Paola L, Silvado CES.
    Epilepsy Behav; 2019 Nov 01; 100(Pt A):106516. PubMed ID: 31574430
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Randomized, double-blind, placebo-controlled trial of acetaminophen for preventing mood and memory effects of prednisone bursts.
    Brown ES, Denniston D, Gabrielson B, Khan DA, Khanani S, Desai S.
    Allergy Asthma Proc; 2010 Nov 01; 31(4):331-6. PubMed ID: 20819324
    [Abstract] [Full Text] [Related]

  • 15. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
    Anand A, Charney DS, Oren DA, Berman RM, Hu XS, Cappiello A, Krystal JH.
    Arch Gen Psychiatry; 2000 Mar 01; 57(3):270-6. PubMed ID: 10711913
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
    Deakin JF, Lees J, McKie S, Hallak JE, Williams SR, Dursun SM.
    Arch Gen Psychiatry; 2008 Feb 01; 65(2):154-64. PubMed ID: 18250253
    [Abstract] [Full Text] [Related]

  • 19. A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine: effects on CSF glutamate, aspartate, branched-chain amino acid levels and clinical parameters.
    Ryberg H, Askmark H, Persson LI.
    Acta Neurol Scand; 2003 Jul 01; 108(1):1-8. PubMed ID: 12807386
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.